Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Azurrx Biopharma Inc (AZRX)

Azurrx Biopharma Inc (AZRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Azurrx Biopharma Inc 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 USA

P: 561-589-7020

Description:

Azurrx Biopharma, Inc. is a biopharmaceutical company. It focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. The company's product pipeline consists of MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency and AZX1101, a recombinant enzyme for the prevention of hospital-acquired C.difficile infections. Azurrx Biopharma, Inc. is headquartered in New York City.

Key Statistics

Overview:

Market Capitalization, $K 32,175
Shares Outstanding, K 9,326
Annual Sales, $ 0 K
Annual Net Income, $ -32,670 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,280 K
60-Month Beta 1.51
% of Insider Shareholders 7.30%
% of Institutional Shareholders 6.27%
Float, K 8,645
% Float 92.70%

Growth:

1-Year Return -54.62%
3-Year Return -86.58%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/20/21
Earnings Per Share ttm -10.80
EPS Growth vs. Prev Qtr -14.29%
EPS Growth vs. Prev Year 5.88%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 09/13/21

AZRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -482.96%
Return-on-Assets % -258.47%
Profit Margin % 0.00
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 8.31
Book Value/Share 0.75
Interest Coverage -4.59
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar